| scholarly article | Q13442814 |
| P2093 | author name string | Jääskeläinen J | |
| Paetau A | |||
| Virkkunen P | |||
| Blomstedt G | |||
| Färkkilä M | |||
| Raininko R | |||
| Kallio M | |||
| Mäntylä M | |||
| Sarelin H | |||
| P2860 | cites work | Modulation of T-cell function by gliomas | Q37543281 |
| The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults | Q37888619 | ||
| Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas | Q38156434 | ||
| Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors | Q40748749 | ||
| Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study | Q48637015 | ||
| New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapy | Q48818649 | ||
| A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma | Q55483561 | ||
| Selection bias in clinical trials of anaplastic glioma. | Q55485061 | ||
| The incidence of intracranial gliomas in southern Finland. | Q55485884 | ||
| Clinical effect of interferon in malignant brain tumours. | Q55488998 | ||
| Natural alpha-interferon in combination with hyperfractionated radiotherapy in the treatment of non-small cell lung cancer | Q67491042 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 138-141 | |
| P577 | publication date | 1994-07-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma | |
| P478 | volume | 70 |
| Q35781959 | An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals |
| Q37970682 | Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment |
| Q37344951 | Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma |
| Q37886819 | Cytokine networks in glioma |
| Q38227496 | Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation |
| Q37594834 | Dendritic cell therapy of high-grade gliomas. |
| Q28485036 | Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy |
| Q47817656 | Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis |
| Q37587832 | Gammadelta T cells as immune effectors against high-grade gliomas |
| Q50867715 | IFN-γ and tumor gangliosides: Implications for the tumor microenvironment. |
| Q38870994 | Immunological Aspects of Malignant Gliomas |
| Q37117689 | Immunotherapeutic treatment strategies for primary brain tumors |
| Q35903574 | Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells |
| Q57451427 | Immunotherapy in CNS cancers: the role of immune cell trafficking |
| Q47817635 | Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells |
| Q73899241 | Local low-dose interleukin-2 induces systemic immunity when combined with radiotherapy of cancer. A pre-clinical study |
| Q33371019 | Maintenance treatment with interferon-gamma and low-dose cyclophosphamide for pediatric high-grade glioma |
| Q37699245 | No role of IFITM3 in brain tumor formation in vivo |
| Q34387557 | Pharmacotherapy of malignant astrocytomas of children and adults: current strategies and future trends |
| Q34075068 | Progress in active-specific immunotherapy of brain malignancies |
| Q34223630 | Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation |
| Q36115400 | Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system |
| Q34552162 | Therapeutic activity of NK cells against tumors |
| Q90583610 | Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis |
| Q39558094 | Zoledronic acid enhances Vδ2 T-lymphocyte antitumor response to human glioma cell lines |
Search more.